Tag
NASDAQ: UNCY
Unicycive Therapeutics reports US$59M ahead of March FDA target
Adrian Kessler · Nov 16, 2026
Unicycive Therapeutics resubmits oxylanthanum carbonate NDA to FDA
Adrian Kessler · Sep 29, 2026